血液静止对STEMI患者的长期心血管结果的重要性-一项前性试点研究
Aleksandra Karczmarska-Wódzka1, Patrycja Wszelaki1, Krzysztof Pstrągowski2
1Research and Education Unit for Experimental Biotechnology, Department of Transplantology and General Surgery, Collegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.
Journal of clinical medicine
|August 14, 2025
概括
在ST升高心肌梗塞 (STEMI) 患者中,血小板活性和凝血参数可以预测不良心血管事件. 识别这些标志物有助于对STEMI幸存者进行风险分层和二次预防策略.
科学领域:
- 心血管医学 心血管医学
- 血液学 血液学 血液学
- 临床研究 临床研究
背景情况:
- 血小板活动是心肌梗塞 (MI) 的关键因素.
- 不充分的血小板抑制会增加支架血栓形成和死亡的风险.
- 识别需要强化二次预防后心脏病发作的患者至关重要.
研究的目的:
- 评估后心脏病发作患者的血小板和凝血活性.
- 为了确定与不良的ST升高心肌梗塞 (STEMI) 结果相关的参数,超过3年.
- 为了帮助STEMI患者的风险分层.
主要方法:
- 对入院的19名STEMI患者的分析.
- 使用血栓形成显微镜 (TEG) 和全血栓形成分析系统 (T-TAS) 来评估血液静止和凝血.
- 与主要心血管不良事件 (MACE) 相关联的实验室参数.
主要成果:
- 患有MACE的患者表现出更快的凝块形成和更大的凝块强度.
- 在患有MACE的患者中观察到较低的T-TAS AUC10值.
- 在MACE患者中,低密度脂蛋白和TEG动态之间存在强烈的负相关性.
结论:
- 特定的血液静止和凝血参数与不良的STEMI结果有关.
- 这些参数可能表明炎症状态.
- 这些发现可以帮助分层风险,并识别需要持续监测的STEMI患者.
相关概念视频
Acute Coronary Syndrome I: Introduction
72
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
72
Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
903
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
903
Introduction to Hemostasis
8.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.9K
Acute Coronary Syndrome IV: Interprofessional Care
27
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
27
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
334
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
334


